EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Urinary peptide signature distinguishes autosomal recessive polycystic kidney disease from other causes of chronic kidney disease

Kathrin Burgmaier iD, Bénédicte Buffin-Meyer, Julie Klein, Brian Becknell, Daryl McLeod, Jan Boeckhaus, Oliver Gross iD, Claudia Dafinger, Justyna Siwy, Stéphane Decramer, Franz Schaefer, Max C Liebau iD und 1 weitere

Clinical Kidney Journal · 01.05.2025 · 18 (5)

DOI: 10.1093/ckj/sfaf093 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Kidney Journal, online erschienen am 15.04.2025. Verfasst von Kathrin Burgmaier und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University Hospital Cologne and University of Cologne, Faculty of Medicine, Cologne, Germany. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The diagnosis of autosomal recessive polycystic kidney disease (ARPKD) can be hampered by its pronounced phenotypic variability and ARPKD-mimicking phenocopies. Here, for the first time we specifically studied the urinary peptidome of patients with ARPKD with the aim of distinguishing ARPKD from other causes of chronic kidney disease (CKD).

Methods

Fifty-eight urine samples from patients with ARPKD, 662 urine samples from paediatric patients with CKD with various other CKD aetiologies and 45 samples from healthy children were included. The urinary peptidome was analysed by capillary electrophoresis/mass spectrometry.

Results

A 77-peptide signature specific for ARPKD was identified. Application of this signature in a matched random validation set of 19 samples of patients with ARPKD, 23 samples from patients with other CKD and 21 samples from healthy individuals led to a sensitivity of 84.2% [95% confidence interval (CI) 60.4–96.6], a specificity of 100% (95% CI 92.0–100%) and an area under the receiver operating characteristics curve (AUC) of 0.994 (95% CI 0.93–1.00). The 77-peptide signature displayed a specificity of 76.1% (95% CI 72.4–79.5) and an AUC of 0.88 (95% CI 0.85–0.90) in 591 samples from non-matched children with various CKD aetiologies. The signature was primarily (83%) composed of collagen fragments indicating structural damage. Of the remaining peptides, five originated from proteins known to bind to calcium potentially linking the current work to defaults in calcium signalling in polycystic disease.

Conclusions

We determined a urinary peptide signature that identifies paediatric patients with ARPKD with high precision among a population of children with CKD. Knowledge of the identity of the underlying peptides offers a novel starting point for discussion of possible pathophysiological processes involved in ARPKD.

Schlagwörter

Stichwörter der Autor:innen

ARPKDchronic kidney diseasepeptidomepolycystic kidney diseaseurinalysis

Autor:innen und Institutionen

  • Department of Pediatrics, University Hospital Cologne and University of Cologne, Faculty of Medicine, Cologne, Germany.
  • Faculty of Applied Healthcare Science, Deggendorf Institute of Technology, Deggendorf, Germany.
  • Institut National de la Santé et de la Recherche Médicale (INSERM), Institut of Metabolic and Cardiovascular Disease (I2MC), Toulouse, France.
  • University of Toulouse, Toulouse, France.
  • Kidney and Urinary Tract Center, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH USA.
  • Clinic of Nephrology and Rheumatology, University Medical Center Goettingen, Goettingen, Germany.

ORCID-Profile: Kathrin Burgmaier, Oliver Gross, Max C Liebau, Joost P Schanstra

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Burgmaier, K., Buffin-Meyer, B., Klein, J., Becknell, B., McLeod, D., Boeckhaus, J., Gross, O., Dafinger, C., Siwy, J., Decramer, S., Schaefer, F., Liebau, M. C., & Schanstra, J. P. (2025). Urinary peptide signature distinguishes autosomal recessive polycystic kidney disease from other causes of chronic kidney disease. Clinical Kidney Journal, 18(5). https://doi.org/10.1093/ckj/sfaf093

Vancouver

Burgmaier K, Buffin-Meyer B, Klein J, Becknell B, McLeod D, Boeckhaus J, et al. Urinary peptide signature distinguishes autosomal recessive polycystic kidney disease from other causes of chronic kidney disease. Clinical Kidney Journal. 2025;18(5). doi:10.1093/ckj/sfaf093

BibTeX
@article{Burgmaier2025,
  author = {Burgmaier, Kathrin and Buffin-Meyer, Bénédicte and Klein, Julie and Becknell, Brian and McLeod, Daryl and Boeckhaus, Jan and Gross, Oliver and Dafinger, Claudia and Siwy, Justyna and Decramer, Stéphane and Schaefer, Franz and Liebau, Max C and Schanstra, Joost P},
  title = {Urinary peptide signature distinguishes autosomal recessive polycystic kidney disease from other causes of chronic kidney disease},
  journal = {Clinical Kidney Journal},
  year = {2025},
  volume = {18},
  number = {5},
  doi = {10.1093/ckj/sfaf093}
}
Kostenlos starten →